Neuland Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2025 ,inter alia, to consider and approve the Audited Standalone ....
NEULANDLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Neuland Laboratories has informed the stock exchanges that its Board of Directors will meet on Thursday, May 15, 2025. The main agenda is to consider and approve the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2025 (Q4 FY25 and full year FY25). The Board will also consider recommending a final dividend, if any, for FY 2024-25. The trading window for dealing in the company's shares remains closed from April 1, 2025 until 48 hours after the results and dividend announcement are made to the exchanges. No actual financial numbers have been disclosed in this filing as it is only a pre-meeting notice.
This is a routine pre-results announcement with no direct impact on share price. Investors should watch the May 15 results for actual performance and any dividend declaration, which could influence sentiment.